References
- Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003;9:331–8.
- Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005;5:215–29.
- Ferenci P, Fried MW, Shiffman ML, Smith CI, Marinos G, Gonales FL Jr, Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin. J Hepatol 2005;43:425–33.
- Carreño V, Pardo M, López-Alcorocho JM, Rodríguez-Iñigo E, Bartolomé J, Castillo I. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels. J Infect Dis 2006;194:53–60.
- Barría MI, Vera-Otarola J, León U, Vollrath V, Marsac D, Riquelme A, Influence of extrahepatic viral infection on the natural history of hepatitis C. Ann Hepatol 2008;7:136–43.
- Halfon P, Bourlière M, Pénaranda G, Khiri H, Ouzan D. Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection. J Clin Microbiol 2006;44:2507–11.
- Perrella O, Sbreglia C, Perrella M, Spetrini G, Gorga F, Pezzella M, Interleukin-10 and tumor necrosis factor-alpha: model of immunomodulation in multiple sclerosis. Neurol Res 2006;28:193–5.
- Brady MT, MacDonald AJ, Rowan AG, Mills KH. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur J Immunol 2003;33:3448–57.
- Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 2005;41:106–14.
- Ciuffreda D, Comte D, Cavassini M, Giostra E, Bühler L, Perruchoud M, Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur J Immunol 2008;38:2665–77.